A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist

This publication has 42 references indexed in Scilit:

• Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (.+-.)-(5Z)-7-[3-endo[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-exo-yl]heptenoic acid
  Journal of Medicinal Chemistry, 1988
• Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta The effect of calcium antagonists
  Atherosclerosis, 1988
• Identification of thromboxane A2 receptor in cultured vascular endothelial cells of rat aorta
  Biochemical and Biophysical Research Communications, 1988
• Specific receptors for thromboxane A 2 in cultured vascular smooth muscle cells of rat aorta
  Biochemical and Biophysical Research Communications, 1988
• Mechanism of antagonism of thromboxane receptors in vascular smooth muscle
  European Journal of Pharmacology, 1987
• Effects of prostaglandins on the cytosolic free calcium concentration in vascular smooth muscle cells
  Biochemical and Biophysical Research Communications, 1986
• Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1983
• Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.
  Circulation, 1980
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
  Annals of the New York Academy of Sciences, 1949